Are treatment goals for ambulatory blood pressure and plasma lipids after stroke often not reached?
For blood pressure (BP) and cholesterol, secondary prevention is far from ideal in post-stroke patients. Compared with OBP, ABP demands more resources, but in turn yields more reliable results and also provides important information about diurnal BP variation. ABP monitoring at least once after stroke should therefore be implemented routinely.
Young-onset T2DM is the more lethal phenotype of diabetes and is associated with a greater mortality, more diabetes complications, and unfavorable cardiovascular disease risk factors when compared with T1DM.